Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial

Documenti analoghi

• Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
  di: Mcshane, H, et al.
  Pubblicazione: (2005)
• Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
  di: Sander, C, et al.
  Pubblicazione: (2009)
• Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.
  di: Ibanga, H, et al.
  Pubblicazione: (2006)
• DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
  di: Mcshane, H
  Pubblicazione: (2008)
• Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
  di: Whelan, K, et al.
  Pubblicazione: (2009)